The mucosal adjuvant effects of cholera toxin and immune-stimulating complexes differ in their requirement for IL-12, indicating different pathways of action

European Journal of Immunology

Volumn 29, Issue 6, 1999, Pages 1774-1784

  Grdic, Dubravka ^a   Smith, Rosemary ^b   Donachie, Anne ^b   Kjerrulf, Martin ^a   Hörnquist, Elisabeth ^a   Mowat, Allan ^b   Lycke, Nils ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Adjuvant; Cholera toxin; IL 12; Immune stimulating complex; Mucosal immunity

Indexed keywords

ADJUVANT; CHOLERA TOXIN; IMMUNOGLOBULIN A; INTERLEUKIN 12; ISCOM; OVALBUMIN;

ANIMAL EXPERIMENT; ANTIGEN PRESENTATION; ARTICLE; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; MOUSE; MUCOSAL IMMUNITY; NONHUMAN; PRIORITY JOURNAL;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, ORAL; ANIMALS; BASE SEQUENCE; CHOLERA TOXIN; DNA PRIMERS; IMMUNE TOLERANCE; IMMUNITY, MUCOSAL; IMMUNOGLOBULIN G; INTERLEUKIN-12; ISCOMS; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; OVALBUMIN; RNA, MESSENGER; T-LYMPHOCYTES;

EID: 0033029562     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1521-4141(199906)29:06<1774::AID-IMMU1774>3.0.CO;2-1     Document Type: Article

References (28)

1. Mowat, A. M. and Viney, J. L., The anatomical basis of intestinal immunity. Immunol. Rev. 1997. 156: 145-166.
2. Levine, M. M. and Dougan, G., Optimism over vaccines administered via mucosal surfaces. Lancet 1998. 351: 1375-1376.
3. Lycke, N., The mechanism of cholera toxin adjuvanticity. Res. Immunol. 1997. 148: 504-520.
4. Mowat, A. M., Smith, R. E., Donachie, A. M., Furrie, E., Grdic, D. and Lycke, N., Oral vaccination with immune stimulating complexes. Immunol. Lett. 1999. 65: 133-140.
5. Mowat, A. M., Maloy, K. J. and Donachie, A. M., Immune stimulating complexes as adjuvants for inducing local and systemic immunity after oral immunisation with protein antigens. Immunology 1993. 80: 527-534.
6. Smith, R. E., Donachie, A. M., McLaren, F. H. and Mowat, A. M., Preservation of mucosal and systemic adjuvant properties of ISCOMS in the absence of functional interleukin-4 or interferon-γ. Immunology 1998. 93: 556-562.
7. Vajdy, M., Kosco-Vilbois, M., Kopf, M., Köhler, G. and Lycke, N., Impaired mucosal immune responses in interleukin 4-targeted mice. J. Exp. Med. 1995. 181: 41-53.
8. + Th2 cells producing IL-6 and IL-10 are associated with mucosal IgA responses. Infect. Immun. 1996. 64: 516-1525.
9. Spangler, B. D., Structure and function of cholera toxin and the related Escherichia coli heat-labile enterotoxin. Microbiol. Rev. 1992. 56: 622-647.
10. Morein, B., Sundquist, B., Höglund, S. and Dalsgaard, K., Iscom, a novel structure for antigenic presentation of membrane proteins from enveloped viruses. Nature 1984. 308: 457-460.
11. Mowat, A. M., Donachie, A. M., Reid, G. and Jarrett, O., Immune stimulating complexes containing Quil-A and protein antigen prime class I MHC restricted T lymphocytes in vivo and are immunogenic by the oral route. Immunology 1991. 72: 317-322.
12. Villacres-Eriksson, M., Behboudi, S., Morgan, A. J., Trinchieri, G. and Morein, B., Immunomodulation by Quillaja saponaria adjuvant formations: In vivo stimulation of interleukin 12 and its effects on the antibody response. Cytokine 1997. 9: 73-82.
13. Lövgren, K. and Morein, B., The requirement of lipids for the formation of immunostimulating complexes (ISCOMS). Biotechnol. Appl. Biochem. 1988. 10: 161-172.
14. Bowen, J. C., Nair, S. K., Reddy, R. and Rouse, B. T., Cholera toxin acts as a potent adjuvant for the induction of cytotoxic T-lymphocyte responses with nonreplicating antigens. Immunology 1994. 81: 338-342.
15. Villacres-Eriksson, M., Bergström-Mollaoglu, M., Kaberg, H., Lövgren, K. and Morein, B., The induction of cell-associated and secreted IL-1 by ISCOMS, matrix or micelles in murine splenic cells. Clin. Exp. Immunol. 1993. 93: 120-125.
16. Smith, R. E., Donachie, A. M., Grdic, D., Lycke, N. and Mowat, A. M., Immune stimulating complexes induce an IL-12 dependent cascade of innate immune responses. J. Immunol. 1999. 162, in press.
17. Trinchieri, G., Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigenic-specific adaptive immunity. Ann. Rev. Immunol. 1995. 13: 251-276.
18. Xu-Amano, J., Jackson, R., Fujihashi, K., Kiyono, H., Staats, H. and McGhee, J. R., Helper Th1 and Th2 cell responses following mucosal or systemic immunization with cholera toxin. Vaccine 1994. 12: 903-911.
19. Braun, M. C., He, J., Wu, C.-Y. and Kelsall, B. L., Cholera toxin suppresses interleukin (IL)-12 production and IL-12 Receptor beta1 and beta2 chain expression. J. Exp. Med. 1999. 189: 541-552.
20. + cell responses by oral or parenteral immunisation with ISCOMS. Eur. J. Immunol. 1995. 25: 2835-2841.
21. Marth, T., Strober, W., Seder, R. A. and Kelsall, B., Regulation of transforming growth factor-B production by interleukin-12. Eur. J. Immunol. 1997. 27: 1213-1220.
22. + T cells in the normal gut mucosa. J. Immunol. 1998. 160: 754-762.
23. Magram, J., Connaughton, S. E., Warrier, R. R., Carvajal, D. M., Wu, C.-Y., Ferrante, J., Stewart, C., Sarmiento, U., Faherty, D. A. and Gately, M. K., IL-12-deficient mice are defective in IFN-g production and type 1 cytokine responses. Immunity 1996. 4: 471-481.
24. Dunn-Walters, D. K., Isaacson, P. G. and Spencer, J., Sequence analysis of human IgVh genes indicates that ileal lamina propria plasma cells are derived from Peyer's patches. Eur. J. Immunol. 1997. 27: 463-467.
25. Yamamoto, M., McGhee, J. R., Rennert, P., Yamamoto, S., Kweon, M., Dohi, T., Bluethmann, H., Fujihashi, K. and Kiyono, H., Organized Peyer's patches are not required for mucosal IgA responses in the gut of LT-beta receptor-Ig treated mice. FASEB J. 1998. 12: A884.
26. Ågren, L. C., Ekman, L., Löwenadler, B. and Lycke, N. Y., A genetically engineered nontoxic vaccine adjuvant that combines B cell targeting with immunomodulation by cholera toxin A1 subunit. J. Immunol. 1997. 158: 3936-3946.
27. Viney, J. L., Mowat, A. M., O'Malley, J. M., Williamson, E. and Fanger, N. A., Expanding dendritic cells in vivo enhances the induction of oral tolerance. J. Immunol. 1998. 160: 5815-5825.
28. Friedman, A. and Weiner, H.L., Induction of anergy or active suppression following oral tolerance is determined by antigen dosage. Proc. Natl. Acad. Sci. USA 1994. 91: 6688-6692.